Frederic H. Moll is Director at ShockWave Medical, Inc. (SWAV). They have made 30 open-market trades across 7 companies since 2008, most recently 2026-06-09.
CIK 0001260157
19 open-market purchases totalling $47.7M since 2008, against 11 sales. Across 10 scored buys the stock is down 21.0% at ninety days, and 20.5 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 10% | 20% | 10% |
| Avg Move | -17.1% | -4.0% | -21.0% |
| Alpha | -13.4% | -5.0% | -20.5% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SSII | BUY | 2026-03-06 | 2026-03-10 | $3.99 | $2.0M | -2.0% | -12.7% | -28.6% |
| PRCT | BUY | 2025-08-13 | 2025-08-14 | $39.26 | $785K | -2.9% | -8.9% | -26.2% |
| SSII | BUY | 2025-02-20 | 2025-02-24 | $1.37 | $10.0M | -33.9% | -26.8% | -54.3% |
| SSII | BUY | 2025-01-09 | 2025-01-10 | $1.37 | $4.0M | -33.9% | -26.8% | -26.8% |
| SSII | BUY | 2024-12-31 | 2025-01-03 | $1.37 | $6.0M | -33.9% | -26.8% | -26.8% |
| SSII | BUY | 2024-11-25 | 2024-11-27 | $1.37 | $10.0M | -33.9% | -26.8% | -26.8% |
| SWAV | SELL | 2024-02-21 | 2024-02-22 | $257.15 | $28.6M | -6.4% | +6.7% | +24.1% |
| PRCT | SELL | 2023-12-06 | 2023-12-08 | $38.75 | $6.1M | +2.6% | +8.2% | +26.4% |
| PRCT | BUY | 2021-09-17 | 2021-09-21 | $25.00 | $10.0M | -0.1% | +10.3% | -35.2% |
| SWAV | SELL | 2019-10-07 | 2019-10-09 | $31.62 | $949K | +13.9% | +14.3% | +47.0% |
| HAIR | BUY | 2018-08-09 | 2018-08-13 | $1.50 | $1000K | +5.1% | +82.2% | +19.1% |
| XENT | SELL | 2017-11-16 | 2017-11-20 | $28.76 | $408K | +3.8% | +13.4% | +27.6% |
| XENT | SELL | 2017-11-10 | 2017-11-14 | $29.00 | $23K | +7.5% | +14.2% | +29.0% |
| XENT | SELL | 2016-03-14 | 2016-03-16 | $18.53 | $24K | +6.1% | +11.6% | -14.2% |
| XENT | SELL | 2016-03-08 | 2016-03-09 | $18.56 | $11K | -11.1% | -0.9% | -20.5% |
| XENT | SELL | 2016-03-03 | 2016-03-07 | $18.32 | $229K | -13.2% | +1.2% | -23.5% |
| XENT | SELL | 2015-09-11 | 2015-09-15 | $25.21 | $252K | -14.6% | -3.7% | -3.7% |
| MAKO | BUY | 2012-05-11 | 2012-05-11 | $24.15 | $121K | N/A | N/A | N/A |
| HNSN | SELL | 2012-03-01 | 2012-03-05 | $3.17 | $110K | -17.9% | -2.0% | -2.0% |
| HNSN | SELL | 2011-12-14 | 2011-12-16 | $2.48 | $33K | -17.9% | -2.0% | -2.0% |
| MAKO | BUY | 2011-12-09 | 2011-12-09 | $24.95 | $125K | N/A | N/A | N/A |
| MAKO | BUY | 2011-11-21 | 2011-11-22 | $27.01 | $100K | N/A | N/A | N/A |
| MAKO | BUY | 2011-06-08 | 2011-06-10 | $30.49 | $91K | N/A | N/A | N/A |
| MAKO | BUY | 2010-05-10 | 2010-05-12 | $12.67 | $950K | N/A | N/A | N/A |
| HNSN | BUY | 2010-04-16 | 2010-04-19 | $2.00 | $1.8M | -17.9% | -2.0% | -2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| BIOL | 251,317 | $32K |
| MAKO | 234,168 | — |
| Total | $164.9M |
Shares reported on the most recent Form 4, priced at the 2026-06-10 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.